SPONSORS & EXHIBITOR COMPANY PROFILE

SPONSORS & EXHIBITOR COMPANY PROFILE

Alira Health                                                                    

1 Grant Street, 4th Floor
Framingham
01702
USA
Booth #: 18

Website:  www.alirahealth.com

Alira Health is an integrated Management, Regulatory, and Clinical Strategy advisory firm with offices across the US, Europe, and Japan.  With a strong focus in supportive care and oncology, we support our partners in projects such as portfolio management (i.e. asset prioritization and valuation), clinical strategy and clinical trial design, as well as commercial and clinical positioning for pipeline drugs and devices. In early 2018, Alira Health acquired Clinical Assistance Programs (CAP), widely recognized as one of the world's leading supportive care CRO's, which now operates under the Alira Health name and continues to offer comprehensive CRO services.


Angelini S.P.A.                                                                                                                       

Piazzale della Stazione, snc

Santa Palomba – Pomezia

00071

Italy

Booth #: 14

Website: www.angelinipharma.com                               

Angelini is a privately-held international pharmaceutical company. Founded in Italy in the early 20th century, it has branches in 20 Countries and employs 6.000 people. Pharma is the core business of the group, representing over 50% of the company's €1.6 billion 2016 revenue. Angelini focuses his research and commercial activities mainly on infection control and infectious diseases, pain and inflammation disorders, nervous system diseases and disorders.  R&D department, which synthetized molecules of world-wide importance, like benzydamine, prulifloxacin and trazodone, has full development capabilities and is currently engaged in research projects in all the core business area.


AOP Orphan Pharmaceuticals AG

Wilhelminenstrasse 91/IIf

Vienna

1160

Austria

Booth #: 01

Website: www.aoporphan.com/                                      

AOP Orphan researches, develops, produces and distributes innovative drugs and administration methods for rare diseases – and has become a European pioneer in the field of orphan diseases. Our focus is on the areas of hematooncology, cardiology and pulmonology, neurology and metabolic disorders.


BrainCool AB

Scheelevagen 2

Lund

223 81

Sweden

Booth #: 12

Website: www.braincool.se                                               

BrainCool AB (publ) is an innovative medical device company that develops, markets, and sells leading medical cooling systems for indications and areas with significant medical benefits within the healthcare sector. The company focuses on two business segments, Brain Cooling and Pain Management. BrainCool AB (publ) is based in Lund, Sweden, and its share is listed on AktieTorget.


Camurus

Ideon Science Park

Lund

SE-223 70

Sweden

Booth #: 02A

Website: www.camurus.com                                             

Camurus is a research-focused pharmaceutical company dedicated to the creation of high value therapeutics addressing significant unmet medical needs. Exploiting the varied benefits of the company's proprietary and award-winning lipid-based FluidCrystal® drug delivery technology, Camurus has developed episil® oral liquid, an innovative product for the relief of intra-oral pain associated with Oral Mucositis. In contact with the oral mucosa, episil® transforms into a strongly protective bioadhesive film, providing rapid and sustained pain relief without systemic side effects. Supplied in a ready-to-use device, episil® helps patients maintain their quality of life while undergoing cancer therapy.


Cancer Intelligence on behalf of iManageCancer

13 King Square Avenue

Bristol

BS2 8HU

UK

Website: imanagecancer.eu/                                             

The iManageCancer project has the goal of improving the lives of people living with chronic illnesses like cancer by harnessing the power of mobile phone technology, and helping those with cancer take control of their disease. The project is a European research activity to empower patients and strengthen their capability to manage their diseases through novel health apps and secure eHealth services.  This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 643529.


Dignitana

10925 Estate Lane #W185

Dallas

75238

USA

Booth #: 02

Website: www.dignicap.com/                                           

Dignitana, a medical technology company based in Lund Sweden with operational headquarters in Dallas, Texas, produces the patented DigniCap® Scalp Cooling System to counteract chemotherapy-related hair loss and contribute to improved patient well-being and quality of life. The system provides continuous cooling with high efficacy, safety and acceptable patient comfort. DigniCap is the only scalp cooling system to receive FDA clearance to reduce the likelihood of chemotherapy-induced alopecia in cancer patients with solid tumors. In the pivotal trial DigniCap prevented hair loss in 66.3% of patients with breast cancer receiving adjuvant chemotherapy as published in JAMA February 2017.


Fresenius Kabi Deutschland GmbH

Else-Kröner-Str. 1

Bad Homburg

61352

Germany

Booth #: 05

Website: www.fresenius-kabi.com                                  

Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The company's products and services are used to help care for critically and chronically ill patients. Product portfolio: I.V. generic drugs, infusion therapies and clinical nutrition products as well as the medical devices for administering these products. Within transfusion technologies, Fresenius Kabi offers products for collection and processing of blood components and for therapeutic treatment of patient blood by apheresis systems. In the field of biosimilars, Fresenius Kabi develops products with a focus on oncology and autoimmune diseases.



Helixor Heilmittel GmbH

Fischermühle 1

Rosenfeld

72348

Germany

Booth #: 09

Website: www.helixor.com                                                

Helixor - the Company for Integrative Medicine  Helixor Heilmittel GmbH is an international pharmaceutical company specialized in the field of integrative oncology. Our principal objective is to improve the quality of life of people with special health conditions during all stages of their disease.   We consider the human being as a whole entity and appreciate each person's individuality. These principles guide us in our daily interactions with colleagues and clients. For more information about Helixor and its portfolio, please visit: www.helixor.com


Helsinn Healthcare SA

Via Pian Scairolo 9

Pazzallo-Lugano

6912

Switzerland

Booth #: 04

Website: www.helsinn.ch                                                   

Helsinn, a privately owned pharmaceutical group has an extensive portfolio of marketed products and a broad development pipeline. Since 1976, Helsinn has been improving the everyday lives of patients, guided by core family values of respect, integrity, quality. It works across pharmaceuticals, biotechnology, medical devices and nutritional supplements and has expertise in research, development, manufacture and the commercialization of therapeutic and supportive care products for cancer, pain and inflammation and gastroenterology. Headquartered in Switzerland, Helsinn has operating subsidiaries in Ireland, US (direct sales & marketing) and a representative office in China and product presence in about 90 countries globally. www.helsinn.com


Kyowa Kirin

3000 Hillswood Drive, Hillswood Business Park

Chertsey, London

KT16 0RS

UK

Booth #: 15

Website: www.international.kyowa-kirin.com            

At Kyowa Kirin International "Commitment to Life" is at our core. With over 500 people focused on this purpose we've become a highly successful and rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of innovative medicines for the treatment of unmet therapeutic needs in major western markets. We are headquartered in Scotland with commercial offices in London, across the EU and New Jersey, USA.  We are proud to sponsor MASCC 2018 and invite you to visit our exhibition booth and attend our symposium about Opioid Induced Constipation at 17.30pm on Friday 29th June.


Medicis Health GmbH

Nymphenburger Str. 4

Munich

80335

Germany

Booth #: 17

Website: www.medicis-health.com                                 

MEDICIS HEALTH develops and markets specialty medical products supporting patients with serious diseases such as cancer, autoimmune and metabolic disease. The primary focus is on disease prevention and the prophylaxis of complications resulting from drugs used for the treatment of the primary disease. In cancer MEDICIS offers two medical products that prevent and treat the skin toxicities of targeted EGFR-therapies, chemotherapy and radiotherapy. In autoimmunity, MEDICIS  offers a topical cream that protects against the side effects of IFN-beta therapy in multiple sclerosis. MEDICIS is a privately owned German company.


Paxman Coolers Limited
International House, Penistone Road, Fenay Bridge

Huddersfield

HD8 0LE

UK

Booth #: 20

Website: www.paxmanscalpcooling.com                      

As the leading global expert in preventing chemotherapy-induced hair loss, Paxman's pioneering scalp cooling system is responsible for helping thousands of people worldwide to keep their hair and dignity during cancer treatment. A family business borne out of our Chairman's wife losing her hair whilst receiving chemotherapy for breast cancer, Paxman know first-hand that this is often devastating.  Patient care is at our heart: it's our goal to ensure that everyone, no matter where in the World, has the opportunity to maintain normality, retain their hair and retain their self-confidence. Paxman - chasing zero hair loss during chemotherapy.


TESARO

1000 Winter Street

Waltham

02451

USA

Website: www.tesarobio.com

TESARO is a biopharmaceutical company devoted to providing transformative therapies to people facing cancer. We see new possibilities to responsibly develop and commercialize innovative treatments where others may not. Relationships are vital to the success of our business, and we are committed to being a trusted partner to the cancer community.


THOR Photomedicine Ltd

Watermeadow House

Chesham

HP51LF

UK

Booth #: 08

Website: www.thorlaser.com                                            

THOR has over 3,000 customers in pioneering clinics and hospitals in more than 70 countries and is the only company with FDA, CE, TGA, Health Canada and NATO clearance. Since 1993 THOR has built an unprecedented and unparalleled Research and Development pedigree with many of the world's leading Universities. Around the world these animal and human healthcare professionals have published over 400 Randomised Controlled Trials using LED and 3b Laser devices and over 4,000 publications altogether.